Inés Arrieta-Aguirre

Inés Arrieta-Aguirre

Auto-generated profile, based on publicly available information

Inés Arrieta-Aguirre

Department of Nursing I, University of the Basque Country EHU, Leioa, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Revista Iberoamericana de Micologia
Verified
Journal Article
Closed access
JGJuan Carlos García-Ruiz
Juan Carlos García-Ruiz
LLLeyre López-Soria
Leyre López-Soria
IOIñigo Olazábal
Iñigo Olazábal
EAElena Amutio
Elena Amutio
IAInés Arrieta-Aguirre
Inés Arrieta-Aguirre
MMMaria Dolores Moragues
Maria Dolores Moragues

1 July 2005 in Vaccine
Verified
Journal Article
Closed access
BGBelén González
Belén González
RRRamsés Reina
Ramsés Reina
IGIker García
Iker García
SASara Andrés
Sara Andrés
IGIdoia Glaria
Idoia Glaria
BABeatriz Amorena
Beatriz Amorena

8 March 2006 in Tissue Antigens
Verified
Journal Article
Closed access
PDF file
IAI. Arrieta‐Aguirre
I. Arrieta‐Aguirre
KGKoldo Garcia-Etxebarria
Koldo Garcia-Etxebarria
BJBegoña M. Jugo
Begoña M. Jugo

7 February 2024 in Mycopathologia
Verified
Journal Article
Open access
PDF file
GCGiulia Carrano
Giulia Carrano
IAInés Arrieta-Aguirre
Inés Arrieta-Aguirre
ADAnder Díez
Ander Díez
MBMarta Bregón-Villahoz
Marta Bregón-Villahoz
IFIñigo Fernandez-De-Larrinoa
Iñigo Fernandez-De-Larrinoa
MMMaria Dolores Moragues
Maria Dolores Moragues
Invasive candidiasis (IC), caused by Candida yeasts, particularly Candida albicans, poses a significant threat with high mortality rates. Diagnosis is challenging due to Candida's common presence in human microbiota. To address this, our research group developed an immunofluorescence assay detecting Candida albicans Germ Tube Antibodies (CAGTA) in IC patients. CAGTA, indicative of invasive processes, is associated with a lower mortality rate in ICU patients. Based on this premise, this study aims to provide results regarding the lack of knowledge about the potential activity of CAGTA against invasive infections in humans caused by the fungus Candida albicans. Therefore, in order to characterize the activity of CAGTA produced by patients with IC, we used sera from 29 patients with IC caused by either C. albicans or non-albicans Candida species. Whole serum IgG antibodies were fractionated into anti-blastospores, CAGTA-enriched, and purified CAGTA and the assessments included XTT colorimetric assays for metabolic activity, CFU counts for viability, and microscopy for growth, viability, and morphological analysis. The CAGTA-enriched IgG fraction significantly reduced the metabolic activity and viability of C. albicans compared to anti-blastospores. Purified CAGTA altered germ tube cell wall surfaces, as revealed by electron microscopy, and exhibited fungicidal properties by DiBAC fluorescent staining. In conclusion, antibodies in response to invasive candidiasis have antifungal activity against Candida albicans, influencing metabolic activity, viability, and cell wall structure, leading to cell death. These findings suggest the potential utility of CAGTA as diagnostic markers and support the possibility of developing immunization protocols against Candida infections.

14 November 2025 in Mycopathologia
Verified
Journal Article
Open access
PDF file
MBMarta Bregón-Villahoz
Marta Bregón-Villahoz
ADAnder Díez
Ander Díez
JGJon Galech
Jon Galech
MCMaria-Soledad Cuétara
Maria-Soledad Cuétara
GCGiulia Carrano
Giulia Carrano
IAInés Arrieta-Aguirre
Inés Arrieta-Aguirre
Invasive candidiasis (IC) is a life-threatening fungal infection caused by Candida species. Current diagnostic methods are based on blood culture of the fungus, a technique with limited sensitivity and slow turnaround times. To address these limitations, novel diagnostic strategies are under investigation. This study evaluates the diagnostic potential of the Candida albicans germ tube protein Hyr1 and a subterminal Hyr1 fragment (D22b), both produced in an eukaryotic expression system, for the diagnosis of IC; for that purpose, recombinant Hyr1 and D22b were expressed in Pichia pastoris and tested by ELISA using sera from 176 patients at risk of invasive fungal infections. The diagnostic performance of these antigens was determined and compared with other biomarkers (CAGTA and β-D-glucan). Interestingly, the recombinant proteins exhibited higher apparent molecular weights than predicted, suggesting the presence of post-translational modifications. Serological detection of antibodies against the recombinant Hyr1 and D22b fragment successfully distinguished patients with IC caused by the most commonly isolated Candida species, achieving sensitivities greater than 70% and specificities above 80%. These findings highlight the potential of the serological detection of antibodies to Hyr1 and D22b as a promising diagnostic approach that overcomes the drawbacks of CAGTA detection and could serve as a valuable complement to blood culture, supporting earlier diagnosis and guiding timely treatment decisions in IC. Furthermore, comparing results obtained with antigens produced in eukaryotic and prokaryotic systems, results suggest that accurate protein folding and post-translational processing influence the success of the diagnostic technique.

16 June 2021 in Infectious Diseases in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
MBMarta Bregón-Villahoz
Marta Bregón-Villahoz
MMMaria Dolores Moragues
Maria Dolores Moragues
IAInés Arrieta-Aguirre
Inés Arrieta-Aguirre
MAMikel Azkargorta
Mikel Azkargorta
LLLucía Lainz
Lucía Lainz
RMRoberto Matorras
Roberto Matorras
Purpose. Some microbiota patterns have been associated with favorable IVF prognosis and others with pathological conditions. The endometrial fluid aspirate (EFA) contains antibacterial proteins that are enriched in implantative IVF cycles, but the antimicrobial effect of EFA has not been addressed. We aimed to evaluate the antimicrobial activity of the human endometrial fluid during the natural cycle. Methods. EFA was obtained through an embryo transfer catheter in 38 women, aged 18-40 years, with regular cycles attending to a fertility clinic. The antimicrobial activity of EFAs was tested against two strains of Staphylococcus aureus; one strain each of Streptococcus agalactiae, Enterococcus faecalis, Escherichia coli, and Klebsiella pneumoniae; and three yeasts (Candida albicans, Candida glabrata, and Candida krusei). Results. All samples exhibited antibacterial activity against S. aureus. In addition, 32.4 of EFAs were active against one of the other microorganisms assayed, 16.2 against two, and 5.4 against four of them. In contrast, none exhibited antibacterial activity against E. coli or K. pneumoniae. The antimicrobial activity differs considerably between EFA samples, and we failed to observe a cycle-related pattern. Conclusions. EFA presented two antimicrobial activity patterns: (a) one common to all the samples, exhibiting activity against S. aureus and lack of activity against E. coli and K. pneumoniae, and (b) an individualized pattern, showing activity against some of the other microorganisms tested. The intensity of antibacterial activity differs between EFA samples. Our data suggest that the uterine microbiota is controlled by means of endometrial fluid components.